These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23813092)

  • 21. Efficacy and safety of intravenous voriconazole and intravenous itraconazole for antifungal prophylaxis in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome.
    Mattiuzzi GN; Cortes J; Alvarado G; Verstovsek S; Koller C; Pierce S; Blamble D; Faderl S; Xiao L; Hernandez M; Kantarjian H
    Support Care Cancer; 2011 Jan; 19(1):19-26. PubMed ID: 19956980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients. Gruppo Italiano Malattie Ematologiche dell'Adulto, Gruppo Italiano Trapianto di Midollo Osseo, Associazione Italiana Ematologia ed Oncologia Pediatrica, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer and Sorveglianza Epidemiologica delle Infezioni Fungine nelle Emopatie Maligne.
    Girmenia C; Aversa F; Busca A; Candoni A; Cesaro S; Luppi M; Pagano L; Rossi G; Venditti A; Nosari AM; ; ; ; ;
    Hematol Oncol; 2013 Sep; 31(3):117-26. PubMed ID: 23037867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.
    Vehreschild JJ; Böhme A; Reichert D; Kiehl MG; Arenz D; Pankraz K; Kochanek M; Ullmann AJ; Cornely OA
    Int J Hematol; 2008 Mar; 87(2):126-131. PubMed ID: 18288564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection].
    Sun HL; Zhou X; Shen YF
    Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183
    [No Abstract]   [Full Text] [Related]  

  • 25. Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
    Martin T; Sharma M; Damon L; Kaplan L; Guglielmo BJ; Working M; O'Malley R; Hwang J; Linker C
    Transpl Infect Dis; 2010 Feb; 12(1):45-50. PubMed ID: 19793068
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Role of voriconazole in critically ill patients with invasive mycoses].
    Alvarez Lerma F
    Rev Iberoam Micol; 2007 Sep; 24(3):209-12. PubMed ID: 17874857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies].
    Feng AM; Wei JY; Yu WJ
    Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficacy and safety of micafungin versus intravenous itraconazole as empirical antifungal therapy for febrile neutropenic patients with hematological malignancies: a randomized, controlled, prospective, multicenter study.
    Jeong SH; Kim DY; Jang JH; Mun YC; Choi CW; Kim SH; Kim JS; Park JS
    Ann Hematol; 2016 Jan; 95(2):337-44. PubMed ID: 26596974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of fungal disease in the setting of neutropenia.
    Walsh TJ; Gamaletsou MN
    Hematology Am Soc Hematol Educ Program; 2013; 2013():423-7. PubMed ID: 24319214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation.
    Marks DI; Pagliuca A; Kibbler CC; Glasmacher A; Heussel CP; Kantecki M; Miller PJ; Ribaud P; Schlamm HT; Solano C; Cook G;
    Br J Haematol; 2011 Nov; 155(3):318-27. PubMed ID: 21880032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection.
    Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ
    Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561
    [No Abstract]   [Full Text] [Related]  

  • 32. Visual disturbance comorbid with hallucination caused by voriconazole in the Japanese population.
    Imataki O; Ohnishi H; Kitanaka A; Kubota Y; Ishida T; Tanaka T
    Int J Hematol; 2008 Jul; 88(1):3-6. PubMed ID: 18574651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoeconomics of voriconazole in the management of invasive fungal infections.
    Al-Badriyeh D; Heng SC; Neoh CF; Slavin M; Stewart K; Kong DC
    Expert Rev Pharmacoecon Outcomes Res; 2010 Dec; 10(6):623-36. PubMed ID: 21155694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.
    Cordonnier C; Rovira M; Maertens J; Olavarria E; Faucher C; Bilger K; Pigneux A; Cornely OA; Ullmann AJ; Bofarull RM; de la Cámara R; Weisser M; Liakopoulou E; Abecasis M; Heussel CP; Pineau M; Ljungman P; Einsele H; ;
    Haematologica; 2010 Oct; 95(10):1762-8. PubMed ID: 20634495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Institutional experience with voriconazole compared with liposomal amphotericin B as empiric therapy for febrile neutropenia.
    Shehab N; DePestel DD; Mackler ER; Collins CD; Welch K; Erba HP
    Pharmacotherapy; 2007 Jul; 27(7):970-9. PubMed ID: 17594202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal prophylaxis in chemotherapy-associated neutropenia: a retrospective, observational study.
    Riedel A; Choe L; Inciardi J; Yuen C; Martin T; Guglielmo BJ
    BMC Infect Dis; 2007 Jul; 7():70. PubMed ID: 17605773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of hepatotoxicity with off-label oral-treatment doses of voriconazole for invasive fungal infections.
    Gorski E; Esterly JS; Postelnick M; Trifilio S; Fotis M; Scheetz MH
    Antimicrob Agents Chemother; 2011 Jan; 55(1):184-9. PubMed ID: 20974867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Voriconazole concentrations and outcome of invasive fungal infections.
    Miyakis S; van Hal SJ; Ray J; Marriott D
    Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole.
    Kobayashi R; Matsushima S; Hori D; Sano H; Suzuki D; Kishimoto K; Nakano T; Yanagi M; Kodama K; Kobayashi K
    Pediatr Int; 2021 May; 63(5):550-555. PubMed ID: 32869416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.